Literature DB >> 22265864

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.

Alison Ribeiro1, Viviane Ferraz-de-Paula, Milena L Pinheiro, Luana B Vitoretti, Domenica P Mariano-Souza, Wanderley M Quinteiro-Filho, Adriana T Akamine, Vinícius I Almeida, João Quevedo, Felipe Dal-Pizzol, Jaime E Hallak, Antônio W Zuardi, José A Crippa, João Palermo-Neto.   

Abstract

Acute lung injury is an inflammatory condition for which treatment is mainly supportive because effective therapies have not been developed. Cannabidiol, a non-psychotropic cannabinoid component of marijuana (Cannabis sativa), has potent immunosuppressive and anti-inflammatory properties. Therefore, we investigated the possible anti-inflammatory effect of cannabidiol in a murine model of acute lung injury. Analysis of total inflammatory cells and differential in bronchoalveolar lavage fluid was used to characterize leukocyte migration into the lungs; myeloperoxidase activity of lung tissue and albumin concentration in the bronchoalveolar lavage fluid were analyzed by colorimetric assays; cytokine/chemokine production in the bronchoalveolar lavage fluid was also analyzed by Cytometric Bead Arrays and Enzyme-Linked Immunosorbent Assay (ELISA). A single dose of cannabidiol (20mg/kg) administered prior to the induction of LPS (lipopolysaccharide)-induced acute lung injury decreases leukocyte (specifically neutrophil) migration into the lungs, albumin concentration in the bronchoalveolar lavage fluid, myeloperoxidase activity in the lung tissue, and production of pro-inflammatory cytokines (TNF and IL-6) and chemokines (MCP-1 and MIP-2) 1, 2, and 4days after the induction of LPS-induced acute lung injury. Additionally, adenosine A(2A) receptor is involved in the anti-inflammatory effects of cannabidiol on LPS-induced acute lung injury because ZM241385 (4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol) (a highly selective antagonist of adenosine A(2A) receptor) abrogated all of the anti-inflammatory effects of cannabidiol previously described. Thus, we show that cannabidiol has anti-inflammatory effects in a murine model of acute lung injury and that this effect is most likely associated with an increase in the extracellular adenosine offer and signaling through adenosine A(2A) receptor. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265864     DOI: 10.1016/j.ejphar.2011.12.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  56 in total

1.  Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Authors:  Attila Oláh; Balázs I Tóth; István Borbíró; Koji Sugawara; Attila G Szöllõsi; Gabriella Czifra; Balázs Pál; Lídia Ambrus; Jennifer Kloepper; Emanuela Camera; Matteo Ludovici; Mauro Picardo; Thomas Voets; Christos C Zouboulis; Ralf Paus; Tamás Bíró
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

2.  Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples.

Authors:  Omayma Alshaarawy; James C Anthony
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

3.  The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model.

Authors:  Rui Li; Guo Chen; Lin Zhou; He Xu; Fei Tang; Jie Lan; Ruizhan Tong; Lei Deng; Jianxin Xue; You Lu
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

4.  Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats.

Authors:  Eric Murillo-Rodríguez; Gloria Arankowsky-Sandoval; Nuno Barbosa Rocha; Rodrigo Peniche-Amante; André Barciela Veras; Sérgio Machado; Henning Budde
Journal:  Neurochem Res       Date:  2018-06-06       Impact factor: 3.996

5.  Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010.

Authors:  Omayma Alshaarawy; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2014-11-28       Impact factor: 4.492

6.  Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults.

Authors:  Larry Keen; Arlener D Turner
Journal:  J Behav Med       Date:  2015-03-03

7.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

8.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 9.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

10.  Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.

Authors:  Peer W F Karmaus; James G Wagner; Jack R Harkema; Norbert E Kaminski; Barbara L F Kaplan
Journal:  J Immunotoxicol       Date:  2012-11-23       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.